Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMolten Ventures Regulatory News (GROW)

Share Price Information for Molten Ventures (GROW)

Share Price is delayed by 15 minutes
Get Live Data
568.50    -10.00 (-1.73%)
Bid:
572.50
Ask:
574.50
Spread: 2.00 (0.349%)
Market Cap: £978.85m
GROW Live PriceLast checked at - London Stock Exchange

Intraday Molten Ventures Share Chart

Form 8.5 (EPT/RI) - Molten Ventures Plc

31 Jan 2024 10:03

RNS Number : 5381B
Numis Securities Limited
31 January 2024
Β 

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Numis Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Molten Ventures plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Molten Ventures plc- (Deutsche Numis Is acting as Lead Financial Adviser, Joint Bookrunner and Joint Corporate Broker to Molten)

(d) Date dealing undertaken:

30/01/2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

Purchases

Β 32,656

259.8200 GBX

254.6000 GBX

1p ordinary

Sales

Β 30,000

255.3540 GBX

255.3540 GBX

Β 

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

Β 

Β 

Β 

Date of disclosure:

31/01/2024

Contact name:

Edward Atkins

Telephone number:

0207 260 1487

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.Β 

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FEREAEFFDEALEFA
Date   Source Headline
1st Dec 20255:15 pmEQSHolding(s) in Company
1st Dec 20257:00 amEQSTransaction in Own Shares
28th Nov 20257:00 amEQSTransaction in Own Shares
27th Nov 20257:00 amEQSTransaction in Own Shares
26th Nov 20257:00 amEQSTransaction in Own Shares
25th Nov 20257:30 amEQSTransaction in Own Shares
25th Nov 20257:00 amEQSInterim Results
24th Nov 20258:56 amEQSHolding(s) in Company
24th Nov 20257:00 amEQSTransaction in Own Shares
21st Nov 20257:00 amEQSTransaction in Own Shares
20th Nov 20257:00 amEQSTransaction in Own Shares
19th Nov 20257:00 amEQSTransaction in Own Shares
18th Nov 20255:35 pmEQSHOL-Holding(s) in Company
18th Nov 20257:00 amEQSTransaction in Own Shares
17th Nov 20255:40 pmEQSHolding(s) in Company
17th Nov 20257:01 amEQSTransaction in Own Shares
14th Nov 20255:40 pmEQSHolding(s) in Company
14th Nov 20257:00 amEQSTransaction in Own Shares
13th Nov 20257:01 amEQSTransaction in Own Shares
12th Nov 20257:00 amEQSTransaction in Own Shares
11th Nov 20257:00 amEQSTransaction in Own Shares
10th Nov 20255:55 pmEQSHolding(s) in Company
7th Nov 20257:01 amEQSTransaction in Own Shares
6th Nov 20257:31 amEQSTransaction in Own Shares
6th Nov 20257:01 amEQSFurther partial realisation of holding in Revolut
5th Nov 20257:01 amEQSTransaction in Own Shares
4th Nov 20257:01 amEQSTransaction in Own Shares
3rd Nov 20257:06 amEQSTotal Voting Rights
3rd Nov 20257:01 amEQSTransaction in Own Shares
31st Oct 20252:01 pmEQSHolding(s) in Company
31st Oct 20257:01 amEQSTransaction in Own Shares
30th Oct 20257:01 amEQSTransaction in Own Shares
29th Oct 20257:01 amEQSNotice of Half Year Results Presentations
29th Oct 20257:01 amEQSTransaction in Own Shares
28th Oct 20257:31 amEQSTransaction in Own Shares
24th Oct 202512:01 pmEQSHolding(s) in Company
24th Oct 20257:01 amEQSTransaction in Own Shares
23rd Oct 20257:31 amEQSTransaction in Own Shares
23rd Oct 20257:01 amEQSHalf Year Trading Update
22nd Oct 20257:01 amEQSTransaction in Own Shares
21st Oct 20257:01 amEQSTransaction in Own Shares*
20th Oct 20257:01 amEQSTransaction in Own Shares
17th Oct 20257:01 amEQSTransaction in Own Shares
16th Oct 20257:01 amEQSTransaction in Own Shares
15th Oct 20257:01 amEQSTransaction in Own Shares
14th Oct 20257:01 amEQSTransaction in Own Shares
13th Oct 20257:01 amEQSTransaction in Own Shares
10th Oct 20257:01 amEQSTransaction in Own Shares
9th Oct 20257:01 amEQSTransaction in Own Shares
8th Oct 20257:01 amEQSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.